{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:10:44Z","timestamp":1790381444449,"version":"4.1.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Thorac Med"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/atm.atm_15_20","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T08:18:16Z","timestamp":1585815496000},"page":"76","source":"Crossref","is-referenced-by-count":13,"title":["Clinical and pathological differences between polymorphonuclear-rich and lymphocyte-rich tuberculous pleural effusion"],"prefix":"10.4103","volume":"15","author":[{"given":"Yiqing","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1817-1737.281864-1","first-page":"1090","volume-title":"Increase in extrapulmonary tuberculosis in England and Wales 1999-2006","author":"Kruijshaar","year":"2009","journal-title":"Thorax"},{"key":"key-10.4103\/1817-1737.281864-2","first-page":"1350","volume-title":"Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006","author":"Peto","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/1817-1737.281864-3","first-page":"160","volume-title":"Tuberculous effusion: ADA activity correlates with CD4+cell numbers in the fluid and the pleura","author":"Gaga","year":"2005","journal-title":"Respiration"},{"key":"key-10.4103\/1817-1737.281864-4","first-page":"451","volume-title":"Update on tuberculous pleural effusion","author":"Light","year":"2010","journal-title":"Respirology"},{"key":"key-10.4103\/1817-1737.281864-5","first-page":"417","volume-title":"Adenosine deaminase in the diagnosis of tuberculous pleural effusion: Is it really an ideal test.A word of caution?","author":"Laniado-Labor\u00edn","year":"2005","journal-title":"Chest"},{"key":"key-10.4103\/1817-1737.281864-6","first-page":"e22637","volume-title":"Immune response to Mycobacterium tuberculosis infection in the parietal pleura of patients with tuberculous pleurisy","author":"Caramori","year":"2011","journal-title":"PLoS One"},{"key":"key-10.4103\/1817-1737.281864-7","first-page":"820","volume-title":"Mycobacterium tuberculosis and polymorphonuclear pleural effusion: Incidence and clinical pointers","author":"Lin","year":"2009","journal-title":"Respir Med"},{"key":"key-10.4103\/1817-1737.281864-8","first-page":"85","volume-title":"Comparison of polymorphonuclear- and lymphocyte-rich tuberculous pleural effusions","author":"Bielsa","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.4103\/1817-1737.281864-9","first-page":"1125","volume-title":"Pleural tuberculosis in the United States: Incidence and drug resistance","author":"Baumann","year":"2007","journal-title":"Chest"},{"key":"key-10.4103\/1817-1737.281864-10","first-page":"153","volume-title":"Neutrophilic loculated tuberculous pleural effusion: Incidence, characteristics and differentiation from complicated parapneumonic effusion","author":"Lee","year":"2016","journal-title":"Am J Med Sci"},{"key":"key-10.4103\/1817-1737.281864-11","first-page":"3240","volume-title":"Resolution of residual pleural disease according to time course in tuberculous pleurisy during and after the termination of antituberculosis medication","author":"Han","year":"2005","journal-title":"Chest"},{"key":"key-10.4103\/1817-1737.281864-12","first-page":"2037","volume-title":"A study of loculated tuberculous pleural effusions treated with intrapleural urokinase","author":"Cases","year":"2006","journal-title":"Respir Med"},{"key":"key-10.4103\/1817-1737.281864-13","first-page":"616","volume-title":"Factors influencing residual pleural opacity in tuberculous pleural effusion","author":"Kwon","year":"2008","journal-title":"J Korean Med Sci"},{"key":"key-10.4103\/1817-1737.281864-14","first-page":"35","volume-title":"Loculated tuberculous pleural effusion: Easily identifiable and clinically useful predictor of positive mycobacterial culture from pleural fluid","author":"Ko","year":"2017","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"key-10.4103\/1817-1737.281864-15","first-page":"419","volume-title":"Diagnostic performance of adenosine deaminase activity in pleural fluid: A single-center experience with over 2100 consecutive patients","author":"Porcel","year":"2010","journal-title":"Eur J Intern Med"},{"key":"key-10.4103\/1817-1737.281864-16","first-page":"981","volume-title":"Tuberculous pleural effusions: Advances and controversies","author":"Vorster","year":"2015","journal-title":"J Thorac Dis"}],"container-title":["Annals of Thoracic Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:47:00Z","timestamp":1786733220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/atm.ATM_15_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["281864"],"URL":"https:\/\/doi.org\/10.4103\/atm.atm_15_20","relation":{},"ISSN":["1817-1737"],"issn-type":[{"value":"1817-1737","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}